Use of first generation transplants of a slow growing solid tumor for the evaluation of new cancer chemotherapeutic agents.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001215:Asparaginase / Q000494:pharmacology; D003510:Cyclohexanes / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D003630:Daunorubicin / Q000494:pharmacology; D005069:Evaluation Studies as Topic; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D051379:Mice; D008815:Mice, Inbred Strains; D009279:Naphthacenes / Q000494:pharmacology; D009368:Neoplasm Transplantation; D009607:Nitrosourea Compounds / Q000494:pharmacology; D009705:Nucleosides / Q000494:pharmacology; D011070:Poly I-C / Q000494:pharmacology; D011714:Pyrans / Q000494:pharmacology; D014184:Transplantation, Homologous
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D003510:Cyclohexanes; D009279:Naphthacenes; D009607:Nitrosourea Compounds; D009705:Nucleosides; D011714:Pyrans; D003520:Cyclophosphamide; D001215:Asparaginase; D011070:Poly I-C; D003630:Daunorubicin